Renuncia del CEO de Novo Nordisk tras ocho años al frente; impacto en México, su mercado clave en Latinoamérica. La marca es ...

Foto: Reuters Novo Nordisk anunció la dimisión de su presidente ejecutivo, Lars Fruergaard Jorgensen, por preocupaciones de que la compañía esté perdiendo su ventaja como pionera en el ...

Revista mercadotecnia publicidad medios marketing digital noticias redes sociales Wegovy México Revista Merca2.0 ...

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market ...

Danish drugmaker Novo Nordisk is teaming up with California-based biotech Septerna to develop new pills to treat obesity, ...

The Novo Nordisk Foundation has pledged up to DKK 380 million ($57.76 million) to the World Health Organization (WHO) to ...

As Denmark's Novo Nordisk shops for its next CEO to replace Lars Fruergaard Jorgensen, it should look across the Atlantic for ...

Novo Nordisk would not comment on the new pharmacy benefits arrangements. But a spokesperson for Eli Lilly told CNBC, "Lilly will continue to work with those in health care, government and the ...

Novo Nordisk is parting ways with its CEO Lars Fruergaard Jørgensen after the two parties mutually agreed that a change of leadership was required amid fierce glucagon-like peptide 1 receptor ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.